Literature DB >> 432773

The effects of a minidose of heparin on peritonitis in rats.

J P O'Leary, F S Malik, R R Donahoe, A D Johnston.   

Abstract

Sprague-Dawley rats with peritonitis treated with either a subcutaneous or intraperitoneal minidose of heparin show a significant increase in survival time when compared with controls. In the treatment groups, adhesions and abscesses were less severe and localized to the area of gangrenous bowel. Heparin also significantly reduced the incidence of recovery of viable bacteria from the blood and peritoneal cavity. These findings may be related to a decreased deposition of fibrinogen within the abdomen or to the early mobilization of fibrin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 432773

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing.

Authors:  K A Houston; D I McRitchie; O D Rotstein
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

2.  Adjuvant effect of heparin on peritonitis induced in rats.

Authors:  M M Bagree; R K Aneja
Journal:  Jpn J Surg       Date:  1983-11

Review 3.  The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.

Authors:  Yan Li; Jun-Feng Sun; Xizhong Cui; Haresh Mani; Robert L Danner; Xuemei Li; Jun-Wu Su; Yvonne Fitz; Peter Q Eichacker
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

4.  Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes.

Authors:  O D Rotstein; T L Pruett; R L Simmons
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

5.  The role of feces, necrotic tissue, and various blocking agents in the prevention of adhesions.

Authors:  J P O'Leary; G Wickbom; S O Cha; A Wickbom
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.